Taken together, these data demonstrate that the GO cellular response to heat gene expression signature associates with oncogenic AR signaling and identifies patients with advanced prostate cancer with poorer prognosis, further supporting the targeting of cellular response to heat stress as a therapeutic strategy in lethal prostate cancer. This evidence concerns the gene AR and prostate cancer.